Jiabo Wang

3.0k total citations
115 papers, 2.6k citations indexed

About

Jiabo Wang is a scholar working on Pharmacology, Epidemiology and Complementary and alternative medicine. According to data from OpenAlex, Jiabo Wang has authored 115 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 34 papers in Epidemiology and 33 papers in Complementary and alternative medicine. Recurrent topics in Jiabo Wang's work include Liver Disease Diagnosis and Treatment (28 papers), Traditional Chinese Medicine Analysis (23 papers) and Pharmacological Effects of Natural Compounds (23 papers). Jiabo Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Traditional Chinese Medicine Analysis (23 papers) and Pharmacological Effects of Natural Compounds (23 papers). Jiabo Wang collaborates with scholars based in China, United States and Hong Kong. Jiabo Wang's co-authors include Xiaohe Xiao, Ruisheng Li, Yanling Zhao, Xiao Ma, Yun Zhu, Yanling Zhao, Ruilin Wang, Ming Niu, Shizhang Wei and Lifu Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hazardous Materials.

In The Last Decade

Jiabo Wang

112 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiabo Wang China 32 1.0k 905 533 506 414 115 2.6k
Yanling Zhao China 32 845 0.8× 1.1k 1.2× 380 0.7× 389 0.8× 286 0.7× 119 2.5k
Ming Niu China 29 887 0.9× 1.2k 1.3× 393 0.7× 289 0.6× 336 0.8× 134 2.5k
Ji‐Xing Nan China 37 830 0.8× 1.5k 1.7× 901 1.7× 419 0.8× 480 1.2× 122 3.4k
Li‐Hua Lian China 31 540 0.5× 1.0k 1.1× 679 1.3× 264 0.5× 301 0.7× 96 2.4k
Shizhang Wei China 29 667 0.6× 894 1.0× 429 0.8× 349 0.7× 138 0.3× 87 2.1k
Robert Domitrović Croatia 28 686 0.7× 748 0.8× 346 0.6× 221 0.4× 370 0.9× 54 2.5k
Huichang Bi China 37 1.3k 1.3× 1.9k 2.1× 508 1.0× 312 0.6× 224 0.5× 178 4.2k
Yanling Zhao China 22 441 0.4× 848 0.9× 292 0.5× 274 0.5× 322 0.8× 76 1.9k
Meinrad Boll Germany 13 1.1k 1.1× 515 0.6× 552 1.0× 188 0.4× 350 0.8× 24 2.1k
Feifei Guo China 22 365 0.4× 1.5k 1.7× 423 0.8× 285 0.6× 125 0.3× 95 2.7k

Countries citing papers authored by Jiabo Wang

Since Specialization
Citations

This map shows the geographic impact of Jiabo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabo Wang more than expected).

Fields of papers citing papers by Jiabo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiabo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabo Wang. The network helps show where Jiabo Wang may publish in the future.

Co-authorship network of co-authors of Jiabo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiabo Wang. A scholar is included among the top collaborators of Jiabo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiabo Wang. Jiabo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tao, Haotian Li, Yun Zhu, et al.. (2020). Clinical Efficacy and Safety of Eight Traditional Chinese Medicine Combined with Entecavir in the Treatment of Chronic Hepatitis B Liver Fibrosis in Adults: A Network Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2020(1). 7603410–7603410. 12 indexed citations
2.
3.
Hu, Xiao, et al.. (2018). [Mechanisms of Hirudo in promoting blood circulation and removing stasis based on network pharmacology].. PubMed. 43(9). 1901–1906. 5 indexed citations
4.
Feng, Wuwen, Zhijie Ma, Yanhui Wang, et al.. (2018). Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. Biomedicine & Pharmacotherapy. 99. 325–333. 48 indexed citations
5.
Lu, Xiaohua, Lu Zhang, Jiabo Wang, et al.. (2018). Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis. Frontiers in Pharmacology. 9. 810–810. 17 indexed citations
6.
Zhang, Dingkun, Xue Han, Peng Tan, et al.. (2017). Establishment of one-step approach to detoxification of hypertoxic aconite based on the evaluation of alkaloids contents and quality. Chinese Journal of Natural Medicines. 15(1). 49–61. 11 indexed citations
7.
Li, Pengyan, Jiabo Wang, Zhirui Yang, et al.. (2016). Inhibition of Sophocarpine on Poly I: C/D-GalN-Induced Immunological Liver Injury in Mice. Frontiers in Pharmacology. 7. 256–256. 11 indexed citations
8.
Zhao, Hongwei, Zhenfang Zhang, Herong Cui, et al.. (2016). Oxymatrine attenuates CCl 4 -induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways. International Immunopharmacology. 36. 249–255. 49 indexed citations
9.
10.
Ma, Xiao, Ming Niu, Yun Zhu, et al.. (2016). Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall.. Frontiers in Pharmacology. 7. 14–14. 48 indexed citations
11.
Ma, Xiao, Xuan He, Yanling Zhao, et al.. (2014). Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2014(1). 328152–328152. 24 indexed citations
12.
Zhao, Kuijun, et al.. (2014). Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. Journal of Zhejiang University SCIENCE B. 15(6). 533–539. 44 indexed citations
13.
Zhao, Yanling, Guangde Zhou, Jiabo Wang, et al.. (2013). Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats. Food and Chemical Toxicology. 58. 242–248. 70 indexed citations
14.
Zhao, Yanling, et al.. (2012). Study on Hot Property of Aconiti Lateralis Radix Praeparata and Its Compatibility with Zingiberis Rhizoma Based on Animal Temperature Tropism. Chinese Herbal Medicines. 4(4). 294–300. 2 indexed citations
15.
Wang, Jiabo, et al.. (2012). Translational medicine:promoting Chinese materia medica modernization into clinic faster and better. Zhongcaoyao. 43(1). 1–8.
16.
17.
Kong, Weijun, Jiabo Wang, Qingce Zang, et al.. (2011). Fingerprint–efficacy study of artificial Calculus bovis in quality control of Chinese materia medica. Food Chemistry. 127(3). 1342–1347. 57 indexed citations
18.
Ren, Yongshen, et al.. (2011). A strategy for the detection of quality fluctuation of a Chinese herbal injection based on chemical fingerprinting combined with biological fingerprinting. Journal of Pharmaceutical and Biomedical Analysis. 56(2). 436–442. 36 indexed citations
19.
Wang, Jiabo, et al.. (2010). Necessity of quantitative experimental identification in controlling quality of traditional medicinal materials based on commercial specification status of Rhei Radix et Rhizoma.. Zhongcaoyao. 41(8). 1225–1230. 1 indexed citations
20.
Wang, Jiabo, et al.. (2009). Investigation of the differences between the “COLD” and “HOT” nature of Coptis chinensis Franch and its processed materials based on animal’s temperature tropism. Science in China Series C Life Sciences. 52(11). 1073–1080. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanling Zhao Breakdown of academic impact, for papers by Ming Niu Breakdown of academic impact, for papers by Ji‐Xing Nan Breakdown of academic impact, for papers by Li‐Hua Lian Breakdown of academic impact, for papers by Shizhang Wei Breakdown of academic impact, for papers by Robert Domitrović Breakdown of academic impact, for papers by Huichang Bi Breakdown of academic impact, for papers by Yanling Zhao Breakdown of academic impact, for papers by Meinrad Boll Breakdown of academic impact, for papers by Feifei Guo
Rankless by CCL
2026